The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
One-year reductions in cisplatin-related chronic kidney disease (CKD) in patients with head and neck (HNC) cancer treated with avasopasem manganese: A prespecified analysis from the phase 3 ROMAN trial.
 
Bryan G. Allen
Research Funding - Galera Therapeutics
 
Douglas R. Spitz
Research Funding - Galera Therapeutics (Inst); University of Iowa (Inst)
Patents, Royalties, Other Intellectual Property - Galera Therapeutics (Inst)
 
Kranti A. Mapuskar
Research Funding - Galera Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Galera Therapeutics (Inst)
 
Diana Zepeda-Orozco
Patents, Royalties, Other Intellectual Property - IP
 
Robert Alan Beardsley
Employment - Euclises; Galera Therapeutics
Leadership - Euclises; Galera Therapeutics
Stock and Other Ownership Interests - Euclises; Galera Therapeutics
Patents, Royalties, Other Intellectual Property - The following patents and applications (as well as related US divisional and international matters) are all assigned to Galera Therapeutics with no further compensation to the discloser. ? Combination cancer immunotherapy with pentaaza macrocyclic ring co
Travel, Accommodations, Expenses - Galera Therapeutics
 
Eugene Paul Kennedy
Employment - CSL Limited (I); Galera Therapeutics
Leadership - Galera Therapeutics
Stock and Other Ownership Interests - CSL Behring (I); Galera Therapeutics; Lumos Pharma
 
Carryn M. Anderson
Employment - University of Iowa Hospitals and Clinics; University of Iowa Hospitals and Clinics (I)
Research Funding - Galera Therapeutics (Inst); Soligenix (Inst)
(OPTIONAL) Uncompensated Relationships - Galera Therapeutics